Analyst Ratings for Intellia Therapeutics (NTLA) [Neutrals]

NTLA Rating Summary

NTLA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on NTLA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $140.63 (-10.6%) * Over Last 12-Mos
Rating Score: 8.4 / 10   Percentile Rank: 86%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/22/2020 Baird Madhu Kumar Downgrade Neutral
(Outperform)
60.00
(N/A)
55.41
(157.29)
183.87% Details
2/14/2020 Wedbush
» Updated 6/28/2021
David Nierengarten Downgrade Neutral
(Outperform)
130.00
(87.00)
15.51
(157.29)
914.12% Details
Like NTLA Ratings? Also take a look at REGN, CRSP, BX, NIO

NTLA Ratings News